NewsBite

Healthcare

Today

Ryan Stokes has joined governments, life and general insurers who have identified the economic unsustainability of medicalising social distress through insurance.

Stokes is half-right about mental health and workers’ comp rorts

Disability insurers do not need government intervention. They need to change products for new customers that tighten eligibility.

This Month

 Contrary to assumptions, health insurance is not the domain of the wealthy.

A GST on health insurance would be the tipping point for members

A 10 per cent increase in premiums would be a self-defeating policy that would hurt households, destabilise the health system, and increase pressure on public hospitals.

VitalTrace wants to improve fetal and maternal well-being during childbirth.

Childbirth medtech eyes US market with $30m raise

Perth-based VitalTrace has tapped Acova Capital to raise funds for its commercialisation push.

Dan Collins founded GenesisCare in Brisbane.

GenesisCare US cancer clinic sale to TPG ends painful chapter

Owner Oaktree Capital is selling the Australian company’s Florida and North Carolina clinics for a fraction of their former value.

A health worker prepares a dose of the Pfizer COVID-19 vaccine.  Pfizer paid $43 mln in Australian income tax last year on $1.1 bln of sales.

Drug giants targeting Australia’s PBS are paying tiny amounts of tax

Global pharmaceutical giants make billions of dollars in Australia but pay a fraction of that in tax. They say the price they get for their drugs is too low.

Advertisement
The Melbourne facility produced 10,000 MDMA capsules in its first production run.

‘Not for everybody’: MDMA production for PTSD begins in Australia

Under tight security, an Australian facility has manufactured 10,000 capsules of the psychedelic drug for the first time.

Ramsay Health Care chief executive Natalie Davis at the Macquarie Australia Conference on Wednesday.

Ramsay to close psychology clinics in blow for mental health patients

The nation’s largest private hospital operator says 17 of its 20 psychology clinics will close by September.

Ashlie Hartigan who is organising the science labs at enGeneIC with scientists in Sydney

Why clinical labs are hot property for asset managers

Wentworth Capital is eyeing a further $600 million in life science property investments with BlackRock.

Telix co-founder and CEO Christian Behrenbruch.

Telix subpoenaed by US regulator over cancer therapy

The Melbourne-based biotech says it has notified ASIC about the investigation by US regulators.

Hayden Brass

How an introvert’s brand raked in $8m in sales

Hayden Brass knew his humble family business could be more. Now the founder of health and wellness company Zea is a 2025 BOSS Young Executive.

Mayne Pharma sells products in Australia and the US for birth control and menopause treatments.

Jefferies, Mayne Pharma in spotlight after suitor’s court win

US medicines giant Cosette has successfully sought confidential modelling that it says could prove it was given incomplete financial information.

.

Mesoblast shares soar 35pc on strong cell therapy sales data

The biotech says sales of its first commercial therapy, Ryoncil, were $20 million in the quarter ending June 30.

Mark De Ambrosis is co-founder and managing director of Armitage Associates.

Armitage readies healthtech for sale, tapping Houlihan Lokey

Mark De Ambrosis’ Armitage first bought into MYP in December 2020, acquiring a stake just north of 50 per cent.

.

Waiting to get rich from biotech? Don’t hold your breath

Regulatory upheaval in the US and a venture capital drought are dampening investor appetites, but there are still diamonds in the rough.

Pro Medicus co-founders Anthony Hall and Sam Hupert.

The 10 wealthiest executives in the ASX 300 revealed

Healthcare and tech company bosses, including the co-founders of the ASX’s newest $30 billion company Pro Medicus, dominate the Rich Bosses list.

Advertisement
Healthscope chief executive Tino La Spina is pitching a plan which will see the hospital operator bid for itself.

Healthscope’s not-for-profit plan to bid for itself

Healthscope’s lenders are weighing up a proposal to restructure the hospital operator into a not-for-profit company which will save $100 million on payroll tax.

Riverside’s Simon Feiglin says private equity needs to tell its stories better.

AI is giving private equity a new headache

The local boss of US private equity group Riverside Company says a kid can use AI to replicate a company’s software in hours. That’s a big new risk to price in.

Peter Scutt - Co-founder and CEO Mable.

New tech deal alert: General Atlantic hires advisers to sell $1b Mable

Mable, a marketplace platform that works with NDIS participants and at-home carers, was founded in 2014 by Peter Scutt and Tony Charara.

Stop the mental health blowout, says Labor MP

Paediatrician and MP Mike Freelander says the way society diagnoses mental health is part of the problem behind a huge rise in compensation claims.

CSL chief executive Paul McKenzie will outline plans to cut the company’s R&D spend at the company’s full-year results next month.

CSL prepares to slash R&D as it grapples with looming Trump tariffs

The market is focused on a mooted 200 per cent levy on the pharmaceutical giant’s goods. There are far more significant changes afoot at the company.

Original URL: https://www.afr.com/topic/healthcare-5y6